Donát Alpár

12PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 14, 2025
Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy-Number-Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B-Cell Acute Lymphoblastic Leukemia.

Donát Alpár, Gábor Bedics, Richárd Kiss

|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistance.

Venu Thatikonda, Hengyu Lyu, Sabine Jurado

|Jun 20, 2023
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.

Gábor Bedics, Bálint Egyed, Lili Kotmayer

|May 27, 2023
Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort.

Orsolya Pipek, Donát Alpár, Orsolya Rusz

|Mar 29, 2023
Landscape of <i>BCL2</i> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.

Lili Kotmayer, Tamás László, Gábor Mikala

|Mar 29, 2023
The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.

Orsolya Pipek, Laura Vizkeleti, Viktória Doma

Pageof 2

Frequent Collaborators

2 joint publications

Csaba Bödör

2 joint publications

Gábor Barna

2 joint publications

Orsolya Pipek

1 joint publications

Karel de Groot